Emilie Bahne
Hellerup, 2900, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The impact of inflammation on women's reproductive health
Journal: Ugeskrift for laeger
Published: May 26, 2026
The health risks and treatment options for women with overweight or obesity seeking pregnancy
Journal: Ugeskrift for laeger
Published: September 05, 2025
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
Journal: European journal of endocrinology
Published: April 11, 2024
Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
Journal: European journal of endocrinology
Published: November 03, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Journal: Diabetes, obesity & metabolism
Published: June 15, 2023
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.
Journal: Journal of clinical medicine
Published: September 02, 2020
Metformin is a possible glucagon-like peptide 1 stimulator
Journal: Ugeskrift for laeger
Published: March 22, 2018
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.
Journal: Diabetes care
Published: May 10, 2016
Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Journal: Diabetes, obesity & metabolism
Published: March 06, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026